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MaOBJECTIVES The goal of this study was to explore sex differences in myocardial remodeling in aortic stenosis (AS) by
using echocardiography, cardiac magnetic resonance (CMR), and biomarkers.
BACKGROUND AS is a disease of both valve and left ventricle (LV). Sex differences in LV remodeling are reported in AS
and may play a role in disease phenotyping.
METHODS This study was a prospective assessment of patients awaiting surgical valve replacement for severe AS using
echocardiography, the 6-min walking test, biomarkers (high-sensitivity troponin T and N-terminal pro–brain natriuretic
peptide), and CMR with late gadolinium enhancement and extracellular volume fraction, which dichotomizes the
myocardium into matrix and cell volumes. LV remodeling was categorized into normal geometry, concentric remodeling,
concentric hypertrophy, and eccentric hypertrophy.
RESULTS In 168 patients (age 70  10 years, 55% male, indexed aortic valve area 0.40  0.13 cm2/m2, mean gradient
47  4 mm Hg), no sex or age differences in AS severity or functional capacity (6-min walking test) were found. CMR
captured sex dimorphism in LV remodeling not apparent by using 2-dimensional echocardiography. Normal geometry
(82% female) and concentric remodeling (60% female) dominated in women; concentric hypertrophy (71% male) and
eccentric hypertrophy (76% male) dominated in men. Men also had more evidence of LV decompensation (pleural
effusions), lower left ventricular ejection fraction (67  16% vs. 74  13%; p < 0.001), and higher levels of N-terminal
pro–brain natriuretic peptide (p ¼ 0.04) and high-sensitivity troponin T (p ¼ 0.01). Myocardial ﬁbrosis was higher in men,
with higher focal ﬁbrosis (late gadolinium enhancement 16.5  11.2 g vs. 10.5  8.9 g; p < 0.001) and extracellular
expansion (matrix volume 28.5  8.8 ml/m2 vs. 21.4  6.3 ml/m2; p < 0.001).
CONCLUSIONS CMR revealed sex differences in associations between AS and myocardial remodeling not evident from
echocardiography. Given equal valve severity, the myocardial response to AS seems more maladaptive in men than
previously reported. (Regression of Myocardial Fibrosis After Aortic Valve Replacement [RELIEF-AS]; NCT02174471.)
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ABBR EV I A T I ON S
AND ACRONYMS
AS = aortic stenosis
AVR = aortic valve
replacement
BSA = body surface area
CMR = cardiac magnetic
resonance
ECV = extracellular volume
fraction
EDVi = indexed end-diastolic
volume




IQR = interquartile range
LGE = late gadolinium
enhancement
LV = left ventricle
LVEF = left ventricular ejection
fraction
LVH = left ventricular
hypertrophy
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2I n aortic stenosis (AS), narrowing of theaortic valve is the hallmark of diseaseprogression, but symptom onset and pa-
tient outcome are also determined by the left
ventricular (LV) response to increasing after-
load (1), which remodels in an attempt to
maintain normal wall stress. This scenario is
highlighted by the limited performance of
markers of valve stenosis in predicting symp-
tom onset (2). In contrast, left ventricular
ejection fraction (LVEF), left ventricular hy-
pertrophy (LVH), and myocardial ﬁbrosis
have all been shown to predict outcomes in
AS (3–10). However, LV remodeling is hetero-
geneous (11–13). Four main geometric pat-
terns have been deﬁned: normal geometry,
concentric remodeling, concentric hypertro-
phy, and eccentric hypertrophy. These pat-
terns are based on LV mass, cavity size, and
the ratio of these 2 factors (14,15). Function-
ally, the spectrum of LV responses ranges
from hypercontractile to “myopathic” states.
Echocardiography and cardiac magnetic
resonance (CMR) are the gold standards for
the assessment of valve severity and LV
geometry/function, respectively. CMR is
also able to quantify focal myocardial ﬁbrosis(4–8) and extracellular expansion (16–18), whereas
blood biomarkers (high sensitivity troponin T [hsTnT]
and N-terminal pro–brain natriuretic peptide
[NT-proBNP]) reﬂect whole heart myocyte death and
increased wall stress.
Sex appears to exert an important inﬂuence on LV
remodeling (11,19,20). Previous research has shown
that men are more likely to have higher indexed LV
mass, lower LVEF, and increased diastolic myocardial
stiffness (21,22), whereas women have more concen-
tric remodeling with higher relative wall thickness
and LVEF. To date, however, most studies have relied
on echocardiography alone, with only limited com-
bined echocardiography and CMR data available (22).
The goal of the present study was to understand the
inﬂuence of sex on AS remodeling by using all avail-
able modalities to investigate patterns of remodeling
at macroscopic and tissue levels.
METHODS
This study was a prospective observational cohort
analysis of patients with severe, symptomatic AS
undergoing aortic valve replacement (AVR) in a single
tertiary referral cardiac center, University College
London Hospital NHS Trust, between January 2012
and January 2015. The study was approved by the
eethical committee of UK National Research Ethics
Service (07/H0715/101) and was registered on
ClinicalTrials.gov (NCT02174471). The study con-
formed to the principles of the Declaration of Helsinki,
and all subjects provided written informed consent.
Patients were recruited before pre-operative eval-
uation, which included a comprehensive assessment
with clinical history, resting blood pressure, 6-min
walk test (23), blood sampling (for hsTnT and
NT-proBNP), electrocardiogram, transthoracic
2-dimensional echocardiogram, and CMR (further de-
tails are given in the Online Appendix). Patients met
the inclusion criteria if they were >18 years of age with
severe AS ($2 of: aortic valve area <1 cm2, peak
pressure gradient>64mmHg, mean pressure gradient
>40 mm Hg, and aortic valve velocity ratio <0.25)
undergoing AVR  coronary artery bypass grafting.
Exclusion criteria were pregnancy/breastfeeding, an
estimated glomerular ﬁltration rate <30 ml/min/1.73
m2, CMR-incompatible devices, inability to complete
the protocol, previous valve surgery, or severe valve
disease other than AS. Overall, 48% of patients
undergoing surgical AVR for severe AS at our institu-
tion during the study period were recruited.
CARDIAC IMAGING. Echocardiography assessed dia-
stolic function and valve area/velocities (with CMR
for regurgitant volumes if needed). CMR cine imaging
assessed LV structure and function, as well as late
gadolinium enhancement (LGE), T1 mapping, and
extracellular volume fraction (ECV) for myocardial
tissue characterization.
Echocardiography. Clinical transthoracic echocardiog-
raphy was performed using a GE Vivid E9 system (GE
Healthcare, Wauwatosa, Wisconsin) with a 4-MHz
transducer, following the guidelines for assessment
of AS severity and diastolic function as recom-
mended by the American and European Societies of
Echocardiography (24). Parameters of AS severity
(energy loss index), myocardial work (myocardial
contraction fraction) (25), end-diastolic wall stress
(26), and vascular afterload (systemic arterial
compliance, systemic vascular resistance, and
valvuloarterial impedance) (27) are detailed in the
Online Appendix.
CMR. CMR was performed at 1.5-T (Magnetom Avanto,
Siemens Medical Solutions, Malvern, Pennsylvania)
using a standard clinical scan protocol with LGE
imaging and T1 mapping (modiﬁed Look-Locker
inversion-recovery) before and after bolus gadolin-
ium contrast (0.1 mmol/kg of gadoterate meglumine
[gadolinium-DOTA, marketed as Dotarem, Guerbet
S.A., Paris, France]). Post-contrast imaging was
performed at 10 min (LGE) and 15 min (T1 mapping).
FIGURE 1 Remodeling by Cardiac Magnetic Resonance and Echocardiography
Cardiac Magnetic Resonance
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Patients were categorized into 4 patterns of left ventricular (LV) geometric adaption: normal geometry, concentric remodeling, concentric hypertrophy, and eccentric
hypertrophy. For cardiac magnetic resonance, categories were deﬁned by using body surface area–indexed LV mass (LVMi), indexed LV end-diastolic volume (EDVi),
and mass/volume ratio. For 2-dimensional echocardiography, categories were deﬁned by using body surface area–LVMi, end-diastolic cavity dimension, and relative wall
thickness.
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3CMR image analysis was performed by using CVI42
software version 5.1.2 [303] (Circle Cardiovascular
Imaging, Calgary, Alberta, Canada) by operators
blinded to clinical parameters.
LGE was quantiﬁed in grams and as a percentage of
the LV using a signal intensity threshold of 3 SDs
above the mean remote myocardium. ECV was calcu-
lated as: ECV ¼ (1– hematocrit)  [DR1myocardium]/
[DR1bloodpool] (28), where DR1 is the difference in
relaxation rates pre- and post-contrast. ECV divides
the myocardium into its cell and matrix compart-
ments, giving insights into tissue-level pattern of LV
remodeling. Total LV matrix and cell volumes were
calculated from the product of LV myocardial volume
and ECV or (1 minus ECV), respectively (Online
Appendix).
PATTERNS OF LV REMODELING. Patients with AS
were categorized into 4 patterns of LV geometric
adaption (Figure 1): normal geometry, concentric
remodeling, concentric hypertrophy, and eccentric
hypertrophy. For CMR, categories were deﬁned by
body surface area (BSA)-indexed left ventricular mass
(LVMi), indexed left ventricular end-diastolic vol-
ume, and mass/volume ratio (14). For echocardiog-
raphy, categories were deﬁned by using BSA-indexedLVMi, end-diastolic cavity dimension, and relative
wall thickness, as previously described (15) (Online
Appendix).
STATISTICAL ANALYSIS. Statistical analyses were
conducted by using SPSS version 22 (IBM SPSS Sta-
tistics, IBM Corporation, Armonk, New York). All
continuous variables are expressed as mean  SD or
median (interquartile range [IQR]) for skewed data.
Categorical variables are expressed as percentages.
Normality was checked by using the Shapiro-Wilk
test. Groups were compared by using independent-
sample Student t tests for normally distributed
continuous variables, the Mann-Whitney U test for
non-normally distributed variables, and the Fisher
exact test or a chi-square test for categorical vari-
ables. A 2-sided p value <0.05 was considered
signiﬁcant.
RESULTS
STUDY POPULATION. There were 181 patients with
severe, symptomatic AS recruited (age 69  10 years;
56% male) representing 48% of all surgical AVRs at
the study institution. Thirteen patients were
excluded: claustrophobia (n ¼ 2), hemodynamic
TABLE 1 Baseline Characteristics
Total
(N ¼ 168, 100%)
Men
(n ¼ 92, 55%)
Women
(n ¼ 76, 45%) p Value
Age, yrs 70  10 70  10 70  10 0.9
Trileaﬂet* 118 (100) 61 (66) 57 (76) 0.2
Bicuspid* 49 (100) 31 (34) 18 (24) 0.2
BSA, m2 1.88  0.21 1.98  0.19 1.76  0.17 <0.001
Comorbidities
Hypertension, % 77 81 73 0.4
SBP, mm Hg 133  18 130  18 137  18 0.01
DBP, mm Hg 75  11 74  10 77  13 0.1
Diabetes, % 26 22 29 0.5
Coronary artery disease, % 30 37 21 0.03
Atrial ﬁbrillation, % 14 16 14 0.7
Smoker, current/ex/never 50/21/97 28/17/46 22/04/51 0.2
Risk scores
STS, % 1.43 (0.98–2.37) 1.31 (0.88–2.32) 1.62 (1.04–2.39) 0.3
EuroSCORE II, % 1.49 (1.01–2.44) 1.42 (0.98–2.47) 1.54 (1.02–2.40) 0.6
Drug history
ACE inhibitor/ARB, % 43 53 31 0.006
Beta-blocker, % 34 32 56 0.5
Statin, % 61 63 59 0.8
Aspirin, % 44 47 41 0.4
Symptomatic (yes/no) 161/7 87/5 74/2 0.3
NYHA functional class 2.3  0.7 2.2  0.8 2.4  0.6 0.1
I 30 23 10
II 79 40 39
III 54 26 28
IV 5 4 1
Chest pain by CCS 0.9
0 115 60 55
1 14 12 2
2 29 9 20
3 10 8 2
Syncope 14 (8) 7 (8) 7 (9) 0.7
Six-min walk test, m 480 (338–600) 510 (360–630) 420 (300–510) 0.02
ECG
LVH by Cornell criteria 43 (26) 25 (27) 18 (24) 0.3
ECG strain 29 (17) 17 (19) 12 (16) 0.5
Blood
NT-proBNP, ng/l 71 (29–238) 94 (36–304) 50 (28–143) 0.04
NT-proBNP ratio 0.18 (0.08–0.69) 0.33 (0.09–1.12) 0.11 (0.05–0.35) 0.04
hsTnT, pmol/l 14 (9–20) 15 (11–25) 12 (7–16) 0.02
Creatinine, mmol/l 81 (70–98) 90 (77–103) 74 (63–86) <0.001
eGFR, ml/min/1.73 m2 74 (63–92) 75 (64–95) 72 (61–86) 0.3
Hematocrit, % 40  4 41  5 39  4 0.01
Values are mean  SD, n (%), n, or median (interquartile range). *One patient had unicuspid AS (female). Bold
indicates p < 0.05.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin-receptor blocker; BSA ¼ body surface area; CCS ¼
Canadian Cardiovascular Society Grading System; DBP ¼ diastolic blood pressure; ECG ¼ electrocardiogram;
eGFR ¼ estimated glomerular ﬁltration rate; EuroSCORE II ¼ European System for Cardiac Operative Risk
Evaluation II score; hsTnT ¼ high-sensitivity troponin T; IQR ¼ interquartile range; LVH ¼ left ventricular hy-
pertrophy; NT-proBNP ¼ N-terminal pro–brain natriuretic peptide; NYHA ¼ New York Heart Association; SBP ¼
systolic blood pressure; STS ¼ Society of Thoracic Surgeons’ risk model score.
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4instability (n ¼ 1), pseudo-severe AS (n ¼ 1), severe
mitral regurgitation (n ¼ 2), and signiﬁcant myocar-
dial bystander disease (cardiac amyloidosis, n ¼ 6;
Fabry disease, n ¼ 1) (29).Characteristics of the remaining 168 patients (age
70  10 years; 55% male; 70% trileaﬂet AS) are sum-
marized in Tables 1 and 2. All but 7 patients were
symptomatic (96%) with dyspnea (82%), chest pain
(32%), and/or syncope (8%). CMR identiﬁed pericar-
dial effusions (>5 mm) in 47 patients and pleural
effusions (>1 cm) in 36 patients (22 with both).
There were no sex differences in the aortic valve
regurgitant fraction (14% vs. 10%; p ¼ 0.1), or mitral
valve regurgitant fraction (3% vs. 6%; p ¼ 0.4).
Furthermore, there were no sex differences in age,
smoking status, diabetes, or hypertension preva-
lence, although ofﬁce systolic blood pressure (130 
18 mm Hg vs. 137  18 mm Hg; p ¼ 0.01) and glyco-
sylated hemoglobin levels (38% [IQR: 35% to 41%] vs.
42% [IQR: 39% to 46%]; p ¼ 0.003) were higher in
women. Coronary artery disease (stenosis >50%) was
more prevalent in men (37% vs. 21%; p ¼ 0.03).
AS SEVERITY AND SEX. There were no sex differ-
ences in standard echocardiographic parameters of
AS severity (valve area, gradient, or velocity ratios)
(Table 2). Advanced echocardiographic parameters
revealed subtle sex differences in AS severity and
vascular load: men had a trend toward lower energy
recovery measured by using the energy loss index
(0.46  0.17 cm2/m2 vs. 0.53  0.30 cm2/m2; p ¼ 0.06)
(30) with larger aortic dimensions (6.4  1.7 cm2 vs.
4.6  1.6 cm2; p < 0.001). Furthermore, men had
lower mean arterial pressure (93  11 mm Hg vs. 97 
12 mm Hg; p ¼ 0.02) and systemic vascular resistance
(1,167 dyne$s$cm5 [IQR, 1,010 to 1,400 dyne$s$cm5]
vs. 1,338 dyne$s$cm5 [IQR: 1,142 to 1,647
dyne$s$cm5]; p ¼ 0.001), although global afterload
assessed according to valvulo-arterial impedance
(p ¼ 0.2) did not differ.
PATTERN OF REMODELING AND SEX. The geometry
and function according to CMR (Table 2) differed
according to sex. Men had larger LV dimensions, even
when indexed (EDVi: 73  23 ml vs. 61  19 ml
[p < 0.001]; ESVi: 27  22 g vs. 18  16 g [p ¼ 0.004])
and greater LVMi (98  23 g/m2 vs. 75  20 g/m2;
p < 0.001) and mass/volume ratio (1.44  0.39 vs. 1.30
 0.28; p < 0.001). There were also marked sex
differences in remodeling (chi-square test ¼ 34;
p < 0.001): normal geometry (82% female) and
concentric remodeling (60% female) were predomi-
nantly seen in women, whereas concentric hypertro-
phy (71% male) and eccentric hypertrophy (76% male)
dominated in men. This outcome was not apparent
according to echocardiography (p ¼ 0.4; female:
normal geometry 56%, concentric remodeling 51%,
concentric hypertrophy 38%, and eccentric hyper-
trophy 39%) (Figure 2).
TABLE 2 Imaging Parameters (Echocardiography and CMR)
Total Men Women p Value
Echocardiography
Vmax, m/s 4.33  0.59 4.38  0.59 4.27  0.59 0.3
Peak gradient, mm Hg 76  20 78  21 75  19 0.4
Mean gradient, mm Hg 47  14 49  15 46  13 0.3
AVA, cm2 0.76  0.27 0.78  0.27 0.74  0.26 0.1
AVAi, cm2/m2 0.40  0.13 0.39  0.13 0.41  0.13 0.3
VTI ratio 0.23  0.08 0.22  0.07 0.24  0.08 0.1
Energy loss index, cm2/m2 0.48  0.19 0.46  0.17 0.53  0.30 0.06
Systemic vascular resistance, dyne*s/cm5 1,237 (1,038–1,550) 1,167 (1,010–1,400) 1,338 (1,142–1,647) 0.001
Systemic arterial compliance, ml/mm Hg*m2 1.35  0.47 1.28  0.49 1.42  0.43 0.06
Zva, mm Hg/ml*m2 4.2  1.2 4.1  1.3 4.4  1.0 0.2
E wave 0.85  0.30 0.83  0.30 0.87  0.29 0.4
E/A ratio 0.97  0.49 1.03  0.59 0.89  0.32 0.1
E deceleration time, ms 237  75 236  82 238  66 0.9
E/e’ ratio 13.6  5.9 13.5  6.2 13.8  5.6 0.8
PASP, mm Hg 30 (25–25) 30 (25–25) 30 (26–35) 0.5
CMR parameters
EDVi, ml/m2 67  22 73  23 61  19 0.001
ESVi, ml/m2 23  20 27  22 18  16 0.001
LVMi, g/m2 88  25 98  23 75  20 0.001
Septal wall thickness, mm 14  3 15  2 13  2 <0.001
Left ventricular diameter, mm 50  7 52  7 47  6 <0.001
Mass/volume ratio 1.37  0.35 1.44  0.39 1.30  0.28 0.001
LAAi, pre-operative, cm2/m2 13.5  3.7 13.6  3.3 13.4  4.1 0.8
LVEF, % 70  15 67  16 74  13 0.001
SVi, ml/m2 45  10 46  12 43  8 0.3
Myocardial contraction fraction, % 0.53  0.15 0.48  0.13 0.59  0.14 0.001
Wall stress index, kPa 1.40  0.29 1.35  0.29 1.46  0.27 0.008
Pattern of remodeling by CMR
Normal geometry 28 (17) 5 (18) 23 (82) Chi-square test ¼ 34;
p < 0.001Concentric remodeling 45 (27) 18 (40) 27 (60)
Concentric hypertrophy 70 (41) 50 (71) 20 (29)
Eccentric hypertrophy 25 (15) 19 (76) 6 (24)
CMR ﬂow
Aortic regurgitant fraction, % 12 (4–35) 14 (6–47) 10 (3–24) 0.1
Mitral regurgitant fraction, % 5 (1–23) 3 (0–24) 6 (1–22) 0.4
Late gadolinium enhancement
3 SDs method, g 9.6 (5.0–22.4) 14.8 (8.4–26.9) 6.0 (4.0–17.4) <0.001
T1 mapping (MOLLI)
T1 myocardium (native, in ms) 1,045  45 1,041  42 1,051  47 0.2
ECV, % 28.6  2.9 28.7  3.1 28.6  2.5 0.2
Cell volume, indexed, ml/m2 65  18 73  17 55  13 <0.001
Matrix volume, indexed, ml/m2 25  9 29  9 21  6 <0.001
Values are mean  SD, median (interquartile range), or n (%). Bold indicates p < 0.05.
AVA¼ aortic valve area; AVAi¼ aortic valve area index; CMR ¼ cardiac magnetic resonance; E¼ peak early velocity of the transmitral ﬂow; e’¼ peak early diastolic velocity of
the mitral annulus displacement; E/A ratio = ratio of peak velocity ﬂow in early diastole (E wave) to peak velocity ﬂow in late diastole (A wave); ECV ¼ extracellular volume;
EDVi ¼ end-diastolic volume index; ESVi ¼ end-systolic volume index; IQR ¼ interquartile range; LAAi ¼ left atrial area index; LVMi ¼ left ventricular mass index; LVEF ¼ left
ventricular ejection fraction; MOLLI¼modiﬁed Look-Locker inversion-recovery; PASP ¼ pulmonary artery systolic pressure measured by echocardiography; SVi ¼ stroke volume
index; Vmax ¼ peak velocity through the aortic valve; VTI ¼ velocity-time-integral; Zva ¼ valvuloarterial impedance.
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5SYMPTOMS AND MYOCARDIAL RESPONSE. No sex
differences in New York Heart Association functional
class were found (p ¼ 0.2). Although men were able to
walk farther than women on the 6-min walk test
assessment (510 m [IQR: 360 to 630 m] vs. 420 m [IQR:
300 to 510 m]; p ¼ 0.02), the percentage-predicted6-min walk test distance (31) did not signiﬁcantly
differ between men and women (97  34% vs. 96 
40%; p ¼ 0.6). LVEF was lower in men than in women
(67  16% vs. 74  13%; p < 0.001) (Table 2). Men had
lower minute work (15.6  4.7 ml*mm Hg/min vs.
17.7  4.5 ml*mm Hg/min; p ¼ 0.005) and myocardial
FIGURE 2 Sex Differences in Left Ventricular Pattern of Remodeling
Cardiac Magnetic Resonance











































(A) Cardiac magnetic resonance found marked sex differences in left ventricular remodeling (chi-square test ¼ 34; p < 0.001). Normal
geometry (82% female) and concentric remodeling (60% female) were predominantly seen in women, whereas concentric hypertrophy (71%
male) and eccentric hypertrophy (76% male) in men. (B) This outcome was not apparent by 2-dimensional (2D) echocardiography (female:
normal geometry 56%, concentric remodeling 51%, concentric hypertrophy 38%, and eccentric hypertrophy 39% [chi-square test ¼ 2.7;
p ¼ 0.4]). Percentages are expressed as male/female split per remodeling category.
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6contraction fraction (48  13% vs. 59  14%;
p < 0.001). Furthermore, both NT-proBNP and hsTnT
were higher in men (NT-proBNP: 94 pmol/l [IQR: 36 to
304 pmol/l] vs. 50 pmol/l [IQR: 28 to 143 pmol/l]
[p ¼ 0.04]; hsTnT: 15 pg/l [IQR: 11 to 25 pg/l] vs. 12 pg/l
[7 to 16 pg/l] [p ¼ 0.01]). Figure 3 displays the distri-
bution of LVEF versus indexed LV mass according to
sex and according to BNP clinical activation, deﬁned
as a NT-proBNP ratio >1 (absolute NT-proBNP con-
centration indexed for the 95th centile of normal
range for age and sex [32]).
FOCAL FIBROSIS, EXTRACELLULAR EXPANSION,
AND SEX. Examples of LGE patterns are shown in
Figure 4. There was more LGE in men according to
both overall prevalence (71% vs. 46%; p < 0.01) and
extent (14.8 g [IQR: 8.4 to 26.9 g] vs. 6.0 g [IQR: 4.0 to
17.4 g]; p < 0.001), although these differences were
not statistically signiﬁcant when expressed as a per-
centage of the LV mass (8.6  5.6% vs. 7.7  5.9%;
p ¼ 0.1). Whereas prevalence of infarct pattern LGE
was the same (men 16% vs. women 17%), noninfarct
pattern LGE was more common in men (59% vs. 37%).
No sex differences in native myocardial T1 or ECV (T1:
1,041  42 ms vs. 1,051  47 ms [p ¼ 0.2]; ECV: 28.6 
3.1% vs. 28.2  2.7% [p ¼ 0.2]) were observed. How-
ever, using the ECV to dichotomize the LVMi into
matrix and cell compartments, both indexed matrix(28.5  8.8 ml/m2 vs. 21.4  6.3 ml/m2; p < 0.001) and
cell volumes (72.7  16.7 ml/m2 vs. 54.7  13.0 ml/m2;
p < 0.001) were higher in men.
DISCUSSION
In this prospective multimodality study of 168 pa-
tients with symptomatic severe AS referred for
surgical AVR, despite the same referral age, valve
severity, and functional status, there were major
sex differences in myocardial remodeling, ﬁbrosis,
and resultant LV function. Our data highlight the
importance of the myocardial response in AS
encompassing a wide geometric and functional
range (Figure 5), which is neither associated with
the hemodynamic severity of the aortic valve ste-
nosis nor observed by using conventional echocar-
diography. Men predominantly had concentric or
eccentric LVH as well as a less favorable, maladap-
tive ventricular phenotype (lower LVEF, higher NT-
proBNP and hsTnT, and more focal ﬁbrosis and
extracellular expansion). In contrast, women
exhibited a possibly more favorable phenotype with
less hypertrophy, less focal ﬁbrosis and extracellular
expansion, and a higher prevalence of normal ge-
ometry or concentric remodeling with higher LVEF.
Although the higher levels of NT-proBNP and hsTnT
could be partially explained by more LVH and larger
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(A) Indexed left ventricular mass (LVMi) and left ventricular ejection fraction (LVEF) by sex. Men had greater LVMi (98  23 g/m2 vs.
75  20 g/m2; p < 0.001) and lower LVEF than women (67  16% vs. 74  13%; p < 0.001). (B) LVMi and LVEF by N-terminal pro–brain
natriuretic peptide (NT-proBNP) ratio greater (gray dots) or less than 1 (blue dots), which were higher in men than women (0.33 [interquartile
range: 0.09 to 1.12] vs. 0.11 [interquartile range: 0.05 to 0.35]; p ¼ 0.04). BSA ¼ body surface area.
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7hearts in men, functional and ﬁbrosis parameters
were consistent with a worse myocardial remodel-
ing in men.
These ﬁndings raise a few key issues. First, given
the stark differences in myocardial remodeling, how
do these affect the interpretation of the hemody-
namic severity of the valve stenosis? Second, these
changes may be adaptive or maladaptive: can LVEF,
NT-proBNP, and hsTnT adequately highlight the
transition into maladaptation, or are other bio-
markers needed? In addition, are blood biomarkers
more informative than imaging? Finally, what are the
mechanisms driving the sex differences in
remodeling?
SEX DIMORPHISM IN MYOCARDIAL RESPONSE. In
this study, women seemed to tolerate a similar level
of valve-related afterload better (women even had
higher blood pressures and fewer cardioprotective
drugs), with better-preserved wall stress and better
systolic pump performance (LVEF and myocardial
contraction fraction) than men. Sex-relateddifferences in myocardial remodeling have been re-
ported in the elderly with or without AS (11,19,33–35).
In animal models, sex dimorphism exists in the
baseline ﬁndings of the heart (difference in size,
physiology, gene proﬁles, and contractile properties),
response to pressure or volume overload (more hy-
pertrophy and dilatation, respectively), and car-
diomyocyte response to aging and modiﬁcation of
cardiac gene expression (36). Cellular, molecular, and
neurohormonal mechanisms for the differential
response in men have been proposed, including
increased interstitial ﬁbrosis, greater activation of
proﬁbrotic and inﬂammatory pathways, and differ-
ential expression of androgen and estrogen receptors
(21,37–39). Although the interplay of protective ef-
fects of estrogens and deleterious effects of andro-
gens may play a key role in the sex dimorphism, the
majority of female patients in our study were post-
menopausal, and none were receiving hormone
replacement therapy. Sex differences in the renin-
angiotensin system, nitric oxide activity, and
norepinephrine release may contribute to differences





(A) No late gadolinium enhancement (LGE). (B) Focal papillary muscle and right ventricular (RV) insertion point LGE. (C) Focal mid-wall LGE in
the anterolateral wall. Diffuse, patchy myocardial LGE ranging from (D) mild to (E) moderate to (F) severe LGE burden, associated with
papillary muscle RV insertion and RV free wall LGE. (G) Noninfarct, subendocardial, and papillary muscle LGE. (H) Dilated cardiomyopathy
pattern LGE. (I) Full thickness infarct in the thinned inferior wall.
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8in LV remodeling (40); similar differences in cardiac
function and arterial hemodynamic variables to those
observed here have also been seen in community-
based samples of older men and women (41). A less
explored possibility is that the myocardium could
have been sex-patterned during cardiac fetal forma-
tion to adapt differently during adult life.DISCORDANCE WITH PREVIOUS ECHOCARDIOGRAPHIC
DATA. Sex dimorphism in cardiac remodeling in AS is
present in the literature but has not been empha-
sized. For example, in an echocardiographic study of
2,017 patients (36% female) awaiting AVR (42), LV
impairment had a 3.5 to 1 male-to-female ratio and
LVEF >70% had a 1:1 male-to-female ratio. Given the




























Normal Geometry Eccentric Hypertrophy
This panel shows 4 images each for all 4 patterns of remodeling: continuous wave Doppler assessment of aortic stenosis severity (top left);
Steady State Free Precession short-axis cine clip demonstrating the pattern of remodeling (as described in Figure 1; top right); phase-
sensitive inversion recovery late gadolinium enhancement image for focal ﬁbrosis (bottom left); extracellular volume fraction map for diffuse
ﬁbrosis (bottom right).
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9study entry sex ratios, if there had been no sex
dimorphism, both of these ratios should have been 1.7
to 1. However, the sex dimorphism of cardiac
remodeling according to CMR was much more
extreme than that according to echocardiography
(Figure 6). There are modality-speciﬁc differences in
ascertainment that could explain this: cross-sectional
echocardiography uses derived wall thickness tocavity width ratios, whereas CMR uses a 3-
dimensional–derived mass to volume ratio (14,22).
Each technique also has indexed sex-speciﬁc refer-
ence ranges and cut-points (Online Appendix), which
could be inaccurate and magnify differences. These
may be differently sensitive to sex-inﬂuenced con-
founders (e.g., a basal septal bulge). Such explana-
tions seem inadequate, however, and the impression
FIGURE 6 Sex Dimorphism in Myocardial Response to AS
Aortic Stenosis
168 patients – pre-surgery
AVAi 0.4 cm2/m2 ; Vmax 4.3 m/s
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Aortic stenosis (AS) is a disease of both valve and LV. Sex differences may play a role in disease phenotyping. The present study investigated
168 patients with severe symptomatic AS by using echocardiography (echo), cardiac magnetic resonance (CMR), and biomarkers. There were
no sex differences in AS severity or functional capacity, but CMR captured a sex dimorphism in the LV remodeling pattern, missed by
2-dimensional echocardiography and more adverse in men with more LV dysfunction (by LVEF, N-terminal pro–brain natriuretic peptide
[NT-proBNP], high-sensitivity troponin T [hsTnT]) and myocardial ﬁbrosis (focal and diffuse). Given equal valve severity, LV associations
with AS appear more maladaptive in men, with more extreme sex differences than previously reported. AVAi ¼ indexed aortic valve area;
Vmax ¼ peak velocity; other abbreviations as in Figures 1 and 3.
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10is that an echocardiography-based approach to
cardiac remodeling has induced an underestimation
of biological sex dimorphism in cardiac remodeling
in AS.
PERSPECTIVE: DO WE NEED SEX-SPECIFIC
THRESHOLDS FOR AVR? Timing of aortic valve
intervention is one of the greatest challenges in AS,
particularly in asymptomatic patients. Recent focus
has turned toward the complex interplay between
aortic valve stenosis, vascular load, and myocardial
response (inappropriate hypertrophy, myocardial
stress [NT-proBNP], ﬁbrosis [troponin, LGE, and
ECV], and myocardial perfusion reserve). Our data
support the notion that we may need to treat men
and women differently because they experience a
different cardiac “milieu,” different combined(valve and vasculature) afterload, and display a
different myocardial response. Crucially, data
showing reverse remodeling after valve replacement
and its impact on outcome are required and pending.
STUDY LIMITATIONS. Only patients with severe
symptomatic AS, and speciﬁcally those referred for
surgery at a specialist center, were included. The study
is therefore not representative of patients treated
medically or by transcatheter AVR, or patients with
milder disease. Other factors, including hypertension
duration and control, duration of severe AS, and cor-
onary artery disease, may in part account for the sex
dimorphism in LV remodeling. CMR inclusion criteria
excluded patients with pacemakers and an estimated
glomerular ﬁltration rate <30 ml/min/1.73 m2;
this approach only excluded 7% of patients and is
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: AS is a disease of
both valve and left ventricle. Sex difference may play a role in
disease phenotyping. This study found sex differences in the
associations between AS and myocardial remodeling that were
more adverse in men, including more LV decompensation and
myocardial ﬁbrosis (focal and diffuse) despite similar valve
severity.
TRANSLATIONAL OUTLOOK: Timing of aortic valve inter-
vention is one of the greatest challenges in AS. Recent focus has
turned toward the complex interplay between valve stenosis,
vascular load, and myocardial response. Sex differences in the
myocardial response suggest that men and women may need to
be managed differently. Crucially, outcome data and reverse
remodeling after valve replacement and its impact on outcome
are required and pending.
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11unlikely to have biased our ﬁndings. No invasive LV
pressure data were obtained; due to stroke risk asso-
ciated with crossing the aortic valve, this measure-
ment is not routinely performed in our institution.
Imprecision in T1 mapping may have been introduced
due to partial-voluming of blood (although this pos-
sibility was minimized by using a 10% offset) (Online
Appendix) and in those patients with atrial ﬁbrillation
(n ¼ 24; 14%). Furthermore, reduced capillary density
(lower ECV) or compensatory vasodilatation (higher
ECV) may confound ECV measurements, which cap-
ture all extracellular space including the intravascular
plasma (43,44). Finally, no data were available on the
duration of AS.
CONCLUSIONS
CMR revealed sex differences in associations between
AS and myocardial remodeling that were not evident
from conventional echocardiography. Given equal
valve severity, the myocardial response to AS seems
more maladaptive in men than previously reported.
These data suggest that more detailed phenotyping of
patients with AS is required; the resultant uncovering
of a maladaptive ventricular response may be inﬂu-
ential in the current debate regarding immediate or
deferred intervention for severe AS.ADDRESS FOR CORRESPONDENCE: Prof. James C.
Moon, Barts Heart Centre, St Bartholomew’s Hospital,
2nd Floor, King George V Block, London EC1A 7BE,
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